Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 15, 1985 - Issue 7
21
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Absorption, distribution and excretion of sultopride in man and several animal species

, , , , &
Pages 605-613 | Received 26 Jun 1984, Published online: 22 Sep 2008
 

Abstract

Single oral and intramuscular doses of 14C-sultopride to rat, rabbit and dog and single oral doses of sultopride to human volunteers were well absorbed.

2. Mean blood levels of total 14C peaked at 0·4–1·1 h and declined with half-lives of 2, 1·5 and 3 h in rat, rabbit and dog, respectively. In man mean serum levels of unchanged drug attained a peak at 1·5 h and were eliminated with a half-life of 3·6 h.

3. Highest concn. of radioactivity were found in rat liver, kidney, hypophysis, submaxillary gland and gastrointestinal tract. The concn. in the cerebrum and cerebellum were low. 14C-Sultopride passed through the placental barrier.

4. 14C-Suttopride was poorly bound to plasma proteins (<25% bound) in all species.

5. Repeated doses of the drug slightly increased the blood and tissue levels of 14C in the rat.

6. Most of the dose was eliminated via the kidneys in all species. Male rats excreted larger amounts of 14C into bile and faeces.

7. A high ratio of A.U.C. (milk)/(blood) (c. 3·5) was found in the lactating rat.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.